Consultorio de Reumatologia

Mexico City CP 07760

0 studies enrolling now · 4 studies all time

What they study most

Lupus Erythematosus, Systemic, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed